Mydecine Innovations Group Inc. (MYCOF)
OTCMKTS
· Delayed Price · Currency is USD
0.0034
0.00 (0.00%)
At close: May 14, 2025
MYCOF Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
209.97K USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 215.62M |
| Elite Pharmaceuticals | 70.00M |
| Northwest Biotherapeutics | 1.38M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
Mydecine Innovations Group News
- 14 days ago - Mydecine Innovations Group Announces Late Filing Of Annual Financial Statements And Management Cease Trade Order - TheNewswire
- 7 weeks ago - Mydecine Innovations Group Announces Changes To Board And Management - TheNewswire
- 1 year ago - Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds - GlobeNewsWire
- 1 year ago - Mydecine Innovations Group Announces Director Resignation - GlobeNewsWire
- 1 year ago - Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound - GlobeNewsWire
- 1 year ago - Mydecine Announces Update Regarding the Special Access Program - GlobeNewsWire
- 1 year ago - Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements - GlobeNewsWire
- 1 year ago - Mydecine Provides Q4 2023 Business Update - GlobeNewsWire